229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.09%
Revenue growth above 1.5x VUZI's 2.92%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
17.94%
Positive gross profit growth while VUZI is negative. John Neff would see a clear operational edge over the competitor.
27.80%
Positive EBIT growth while VUZI is negative. John Neff might see a substantial edge in operational management.
27.80%
Positive operating income growth while VUZI is negative. John Neff might view this as a competitive edge in operations.
22.62%
Positive net income growth while VUZI is negative. John Neff might see a big relative performance advantage.
25.42%
Positive EPS growth while VUZI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
25.86%
Positive diluted EPS growth while VUZI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.65%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.60%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-1.75%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
34.75%
OCF growth above 1.5x VUZI's 11.05%. David Dodd would confirm a clear edge in underlying cash generation.
46.89%
Positive FCF growth while VUZI is negative. John Neff would see a strong competitive edge in net cash generation.
930.36%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
121.26%
5Y revenue/share CAGR above 1.5x VUZI's 27.78%. David Dodd would look for consistent product or market expansions fueling outperformance.
43.64%
3Y revenue/share CAGR under 50% of VUZI's 130.96%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
487.86%
Positive long-term OCF/share growth while VUZI is negative. John Neff would see a structural advantage in sustained cash generation.
159.73%
5Y OCF/share CAGR above 1.5x VUZI's 18.78%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
70.39%
Positive 3Y OCF/share CAGR while VUZI is negative. John Neff might see a big short-term edge in operational efficiency.
1508.05%
Net income/share CAGR above 1.5x VUZI's 5.43% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
147.85%
5Y net income/share CAGR above 1.5x VUZI's 61.49%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
49.33%
Positive short-term CAGR while VUZI is negative. John Neff would see a clear advantage in near-term profit trajectory.
521.47%
10Y equity/share CAGR above 1.5x VUZI's 265.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
14.31%
Below 50% of VUZI's 192.11%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.58%
Below 50% of VUZI's 19.83%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
68.04%
Dividend/share CAGR of 68.04% while VUZI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
40.06%
3Y dividend/share CAGR of 40.06% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
85.82%
Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-33.36%
Inventory is declining while VUZI stands at 7.04%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.73%
Positive asset growth while VUZI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-5.22%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.10%
We’re deleveraging while VUZI stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
1.32%
R&D dropping or stable vs. VUZI's 33.30%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
2.63%
We expand SG&A while VUZI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.
